固有层
结肠炎
细胞凋亡
标记法
免疫组织化学
免疫学
巨噬细胞
抗体
CD11c公司
医学
肠粘膜
M2巨噬细胞
炎症性肠病
炎症
流式细胞术
巨噬细胞极化
清道夫受体
癌症研究
病理
化学
内科学
上皮
生物化学
体外
胆固醇
疾病
表型
脂蛋白
基因
作者
Jie Su,Chenxi Xie,Yiqun Hu,Qiu‐An Huang,Huaxiu Shi,L Wang,Jianlin Ren
出处
期刊:Journal of Crohn's and Colitis
[Oxford University Press]
日期:2021-05-01
卷期号:15 (Supplement_1): S146-S147
标识
DOI:10.1093/ecco-jcc/jjab076.160
摘要
Abstract Background This study aimed to investigate the role of class A1 scavenger receptor (SR-A1) for regulating macrophage function and apoptotic pathway during intestinal inflammation of inflammatory bowel disease (IBD) in a DSS-induced murine colitis model. Methods A murine colitis model was established by feeding with 5% dextran sulfate sodium (DSS). Treatment groups were injected intravenously with SR-A1 antibody (100ug/kg), and control groups were injected with the vehicle only. Inflammatory activity and histological changes were evaluated on Day 8, and the percentage of macrophage markers in lamina propria mononuclear cells (LPMC) was measured by flow cytometer. The apoptosis and proliferation of intestinal epithelial cells were detected by TUNEL and Ki67 staining, and the expressions of related signaling pathway protein were determined with western blot. Results Treatment group showed a preventive effect on colitis symptoms and fewer inflammatory cell infiltrates compared with control group. After SR-A1 antibody treatment, flow cytometry of LPMC indicated that the percentage of F4/80+CD206+ Macrophages was elevated, while the percentage of F4/80+CD11c+ Macrophages was not obviously changed. Immunohistochemistry revealed that TUNEL-positive cells were significantly downregulated and Ki67- positive cells were upregulated in colonic mucosa of treatment group. In addition, the expressions of TLR4, MyD88 and NF-kB proteins in colonic mucosa were decreased after SR-A1 antibody injection. Conclusion Treatment with SR-A1 antibody could ameliorate macrophage-associated inflammatory response and epithelial cell apoptosis in a murine colitis model, which suggested that SR-A1 was a negative regulator of M2 polarization in IBD. SR-A1 mediated its effect by synergizing with TLR4/ MyD88 / NF-kB signaling pathway. Our research identified SR-A1 as a potential therapeutic target in IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI